Researchers have found that the sprout extract of broccoli could prevent people from head and neck cancer. The results of the University of Pittsburgh Cancer Institute (UPCI) study conducted on mice, will be further explored in a human clinical trial, which will recruit participants at high risk for the recurrence of disease later this year.
Lead author Dr. Julie Bauman, co-director of the UPMC Head and Neck Cancer Center of Excellence, said that people who were cured of the disease still faced high risk for a second cancer in their mouth or throat, and, unfortunately, the second cancers were commonly fatal.
Better Survival in Head and Neck Cancer in Antacid Users
Better overall survival was seen in patients with head and neck cancer who used antacid medicines to control acid reflux, found a new study from the University of Michigan Comprehensive Cancer Center.
Advertisement
They were hence developing a safe, natural molecule found in cruciferous vegetables to protect the oral lining where these cancers form.
Previous studies, including large-scale trials in China, have shown that cruciferous vegetables that have a high concentration of sulforaphane - such as broccoli, cabbage and garden cress - help mitigate the effects of environmental carcinogens.
![Radiation Treatment, Drug Therapy Combo Less Toxic for Recurrent Head and Neck Cancers]( "Radiation Treatment, Drug Therapy Combo Less Toxic for Recurrent Head and Neck Cancers")
Patients with a recurrence of head and neck cancer who have previously received radiation treatment can be treated more safely, quickly and with fewer side effects with high doses of targeted radiation known as Stereotactic Body Radiation Therapy (SBRT).
Dr. Bauman collaborated with Daniel E. Johnson, professor of medicine at Pitt and a senior scientist in the UPCI Head and Neck Cancer Program, to test sulforaphane in the laboratory. For several months, Dr. Johnson and his team gave sulforaphane to mice predisposed to oral cancer and found that it significantly reduced the incidence and number of tumors.
The findings were enough to prompt a clinical trial that will recruit 40 volunteers who have been curatively treated for head and neck cancer. The participants will regularly take capsules containing broccoli seed powder to determine if they can tolerate the regimen and whether it has enough of an impact on their oral lining to prevent cancer. From there, larger clinical trials could be warranted.
Dr. Bauman, also an associate professor in Pitt's School of Medicine, said they called it "green chemoprevention," where simple seed preparations or plant extracts were used to prevent disease. It required less money and fewer resources than a traditional pharmaceutical study, and could be more easily disseminated in developing countries where head and neck cancer was a significant problem.
The results were announced at the American Association for Cancer Research (AACR) Annual Meeting in Philadelphia.
Source: ANI
Radiation Treatment, Drug Therapy Combo Less Toxic for Recurrent Head and Neck Cancers
Patients with a recurrence of head and neck cancer who have previously received radiation treatment can be treated more safely, quickly and with fewer side effects with high doses of targeted radiation known as Stereotactic Body Radiation Therapy (SBRT).
Advertisement
Dr. Bauman collaborated with Daniel E. Johnson, professor of medicine at Pitt and a senior scientist in the UPCI Head and Neck Cancer Program, to test sulforaphane in the laboratory. For several months, Dr. Johnson and his team gave sulforaphane to mice predisposed to oral cancer and found that it significantly reduced the incidence and number of tumors.
The findings were enough to prompt a clinical trial that will recruit 40 volunteers who have been curatively treated for head and neck cancer. The participants will regularly take capsules containing broccoli seed powder to determine if they can tolerate the regimen and whether it has enough of an impact on their oral lining to prevent cancer. From there, larger clinical trials could be warranted.
Dr. Bauman, also an associate professor in Pitt's School of Medicine, said they called it "green chemoprevention," where simple seed preparations or plant extracts were used to prevent disease. It required less money and fewer resources than a traditional pharmaceutical study, and could be more easily disseminated in developing countries where head and neck cancer was a significant problem.
The results were announced at the American Association for Cancer Research (AACR) Annual Meeting in Philadelphia.
Source: ANI
Progression-Free Survival in Head and Neck Cancer Improved by Afatinib
Results of a phase III trial show that compared to methotrexate, afatinib significantly improved progression-free survival in patients.
Advertisement
 Diabetics Have Increased Risk of Developing Head and Neck CancersA new study reveals that people suffering from diabetes have an increased risk of developing head and neck cancer. | Advertisement
|
Advertisement
Recommended Reading
Latest Cancer News
The new study uncovers the efficacy of fixed-duration combination treatment in patients with high-risk leukemia.
The approvals of pipeline drugs such as momelotinib and Vonjo for myelofibrosis (a rare type of blood cancer) over some time will handle the critical unmet needs.
New study highlights the dual role that blood vessels can play in cancer immunotherapy and eliciting anti-tumor immune responses or even preventing breast cancer spread.
New study evaluated the association between exposure to the chemical agent orange and the development of blood cancer with increased bleeding and blood clot formation.
Study suggests two-year immunotherapy treatment for advanced lung cancer may be reasonable